Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shane William Charles Kovacs Insider Profile
4 Followers
Shane William Charles Kovacs, EVP, CFO & Head of Corp Dev at PTC Therapeutics, holds 484.99K shares in Olema Pharmaceuticals (Ticker: OLMA), holds 8.85K shares in PTC Therapeutics (Ticker: PTCT). Most recently, Shane William Charles Kovacs Bought ― shares of Olema Pharmaceuticals on Jan 16, 2024 for an estimated value of 351.00K.
Shane William Charles Kovacs PTC Therapeutics (PTCT)EVP, CFO & Head of Corp Dev
PTC Therapeutics (PTCT)
EVP, CFO & Head of Corp Dev
Ranked #11,673 out of 98,743 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+32.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Shane William Charles Kovacs holds in companies
Most Profitable Insider Trade
The most profitable trade made by Shane William Charles Kovacs
Shane William Charles Kovacs's Trading History
PTC Therapeutics
May 11, 2017
EVP, CFO & Head of Corp Dev
Informative Buy
108.50K
$274.79K
Olema Pharmaceuticals
Jan 16, 2024
CH. OPERATING & FINANCIAL OFF
Informative Buy
351.00K
$4.77M
List of latest transactions for each holding click on a transaction to see Shane William Charles Kovacs's performance on stock
You May Also Like
Shane William Charles Kovacs insider profile FAQ
What is the percentage of profitable transactions made by Shane William Charles Kovacs?
The percentage of profitable transactions made by Shane William Charles Kovacs is 60%.
What is the average return per transaction made by Shane William Charles Kovacs?
The average return per transaction made by Shane William Charles Kovacs is 32.30%.
What stocks does Shane William Charles Kovacs hold?
Shane William Charles Kovacs holds: PTCT, OLMA stocks.
What was Shane William Charles Kovacs’s latest transaction?
Shane William Charles Kovacs latest transaction was an Informative Buy of $351.00K.
What was Shane William Charles Kovacs's most profitable transaction?
Shane William Charles Kovacs’s most profitable transaction was an Informative Buy of PTCT stock on May 11, 2017. The return on the trade was 129.30%.
What is Shane William Charles Kovacs's role in PTC Therapeutics?
Shane William Charles Kovacs's role in PTC Therapeutics is EVP, CFO & Head of Corp Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.